Skip to content
Back to feed
AI CuratorAI-generated
Research summary ·
AI summary · not yet reviewedHuman studyCase reportPublished in a peer-reviewed journal

Fatal Neuroinvasive Disease in a Female with Multiple Sclerosis

A 37-year-old woman with multiple sclerosis on long-term rituximab developed rapidly progressive dementia. CSF metagenomic sequencing identified Potosi virus, revealing its genome segments. A postmortem examination indicated diffuse meningoencephalitis with significant T-cell inflammation.

Most relevant to
—
This plain-English summary was written by AI from a published abstract and may contain errors. It is not medical advice. Read the original study and talk to your MS team before making decisions about treatment.
Human efficacy
Not established from this source
Mechanism
Not reported
Evidence strength
Limited
Outcome
Not reported

Why it matters

This finding highlights a potential neuroinvasive capability of Potosi virus in immunocompromised individuals, raising concerns for patients with similar conditions.

What this does not prove

Evidence is limited as it is based on a single case report with no generalizable data.

Next milestone

No next milestone was established from the available source.

Study facts
Study design
Case report
Participants / samples
Not reported
Randomised
Not reported
Controlled
Not reported
Primary endpoint met
Not reported
Relevant MS type
Not reported
Publication date
2026-10-29
Evidence reviewed
Abstract only
Regulatory approval
Not reported
Research areas
Not classified
Biological target
Not reported
Pathway
Not reported
Population
37-year-old woman with multiple sclerosis
Size of effect
Not reported
Secondary endpoints
Not reported
MRI endpoints
Not reported
Biomarkers
Not reported
Safety
Not reported

Original sources

Supporting passages (11)
study designCase report.
subjectsTo establish Potosi virus, a mosquito-borne member of the family Peribunyaviridae, as a neuroinvasive human pathogen.
speciesA 37-year-old woman with multiple sclerosis on long-term rituximab developed rapidly progressive dementia.
publication datePublication date: 2026-10-29
findingsCSF metagenomic sequencing detected all 3 genome segments for Potosi virus.
populationRESULTS: A 37-year-old woman with multiple sclerosis on long-term rituximab developed rapidly progressive dementia.
limitationsTitle: Establishing Potosi Virus as a Human Pathogen: Fatal Neuroinvasive Disease in a B-Cell-Depleted Patient.
peer reviewedPublication types: Journal Article; Case Reports
subjectsMeSH terms: Humans; Female; Fatal Outcome; Adult; B-Lymphocytes; Meningoencephalitis; Multiple Sclerosis; Brain
subjectsPublication types: Journal Article; Case Reports
study designPublication types: Journal Article; Case Reports

AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.

0

Discussion 0 comments

Log in or join to comment.